搜索
Brainstorm Cell Therapeutics Inc
BCLI添加自选
1.170USD
0.0000.00%
收盘 07/02, 13:00（美东）报价延迟15分钟
9.26M总市值
亏损市盈率 TTM
关于 Brainstorm Cell Therapeutics Inc 公司
BrainStorm Cell Therapeutics Inc. 是一家自体成人干细胞疗法开发商，用于治疗衰弱性神经退行性疾病。神经退行性疾病包括肌萎缩侧索硬化症 (ALS)、进行性多发性硬化症 (PMS)、阿尔茨海默病 (AD) 等。该公司从事 NurOwn 技术平台的临床开发和商业化，该平台用于生产自体间充质干细胞-神经营养因子 (MSC-NTF) 细胞。NurOwn 利用细胞培养方法诱导自体骨髓衍生的 MSC 分泌高水平 NTF，调节神经炎症和神经退行性疾病过程，促进神经元存活并改善神经功能。自体 MSC-NTF 细胞用于治疗 ALS。该公司已完成 ALS 的 III 期试验。其全资子公司 BrainStorm Cell Therapeutics Ltd. 拥有将 NurOwn 技术商业化的独家权利。
Brainstorm Cell Therapeutics Inc简介
公司代码BCLI
公司名称Brainstorm Cell Therapeutics Inc
上市日期May 28, 2003
CEOMr. Chaim Lebovits
员工数量27
证券类型Ordinary Share
年结日May 28
公司地址1325 Avenue Of Americas
城市NEW YORK
上市交易所US 'Other OTC' and Grey Market
国家United States of America
邮编10019
电话12014880460
网址https://brainstorm-cell.com/
公司代码BCLI
上市日期May 28, 2003
CEOMr. Chaim Lebovits
Brainstorm Cell Therapeutics Inc公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Uri Yablonka
Mr. Uri Yablonka
Director, Executive Vice President, Chief Business Officer, Secretary
Director, Executive Vice President, Chief Business Officer, Secretary
68.46K
--
Dr. Hartoun Hartounian, Ph.D.
Dr. Hartoun Hartounian, Ph.D.
Executive Vice President, Chief Operating Officer
Executive Vice President, Chief Operating Officer
52.00K
--
Ms. Alla Patlis, CPA
Ms. Alla Patlis, CPA
Interim Chief Financial Officer, Controller
Interim Chief Financial Officer, Controller
44.35K
+2.07%
Dr. Stacy R. Lindborg, Ph.D.
Dr. Stacy R. Lindborg, Ph.D.
Director
Director
44.15K
--
Dr. Irit Arbel, Ph.D.
Dr. Irit Arbel, Ph.D.
Independent Vice Chairman of the Board
Independent Vice Chairman of the Board
41.05K
--
Mr. Nir Naor, CPA
Mr. Nir Naor, CPA
Independent Director
Independent Director
31.47K
+12.18%
Dr. Ibrahim B. (Bob) Dagher, M.D.
Dr. Ibrahim B. (Bob) Dagher, M.D.
Executive Vice President, Chief Medical Officer
Executive Vice President, Chief Medical Officer
--
--
Prof. Jacob A. Frenkel, Ph.D.
Prof. Jacob A. Frenkel, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Menghisteab (Menghis) Bairu, M.D.
Dr. Menghisteab (Menghis) Bairu, M.D.
Independent Director
Independent Director
--
--
Dr. Anthony John (Tony) Polverino, Ph.D.
Dr. Anthony John (Tony) Polverino, Ph.D.
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Uri Yablonka
Mr. Uri Yablonka
Director, Executive Vice President, Chief Business Officer, Secretary
Director, Executive Vice President, Chief Business Officer, Secretary
68.46K
--
Dr. Hartoun Hartounian, Ph.D.
Dr. Hartoun Hartounian, Ph.D.
Executive Vice President, Chief Operating Officer
Executive Vice President, Chief Operating Officer
52.00K
--
Ms. Alla Patlis, CPA
Ms. Alla Patlis, CPA
Interim Chief Financial Officer, Controller
Interim Chief Financial Officer, Controller
44.35K
+2.07%
Dr. Stacy R. Lindborg, Ph.D.
Dr. Stacy R. Lindborg, Ph.D.
Director
Director
44.15K
--
Dr. Irit Arbel, Ph.D.
Dr. Irit Arbel, Ph.D.
Independent Vice Chairman of the Board
Independent Vice Chairman of the Board
41.05K
--
Mr. Nir Naor, CPA
Mr. Nir Naor, CPA
Independent Director
Independent Director
31.47K
+12.18%
常见问题
Brainstorm Cell Therapeutics Inc的前五大股东是谁？
Brainstorm Cell Therapeutics Inc 的前五大股东如下：Mr. Uri Yablonka
有多少机构持有Brainstorm Cell Therapeutics Inc(BCLI)的股份？
截至2026Q1，共有77家机构持有Brainstorm Cell Therapeutics Inc的股份，合计持有的股份价值约为400.00，占公司总股份的0.01%。与2025Q4相比，机构持股有所增加，增幅为-1195352.00。